Onconova Therapeutics (ONTX) Short Interest Ratio & Short Volume → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free ONTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestTrends Onconova Therapeutics Short Interest DataCurrent Short Interest26,200 sharesPrevious Short Interest20,700 sharesChange Vs. Previous Month+26.57%Dollar Volume Sold Short$26,462.00Short Interest Ratio0.6 Days to CoverLast Record DateMarch 31, 2024Outstanding Shares21,000,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume1,281,800 sharesAverage Trading Volume96,681 sharesToday's Volume Vs. Average1,326% Short Selling Onconova Therapeutics ? Sign up to receive the latest short interest report for Onconova Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartONTX Short Interest Over TimeONTX Days to Cover Over TimeONTX Percentage of Float Shorted Over Time Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. Onconova Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202426,200 shares $26,462.00 +26.6%N/A0.6 $1.01 3/15/202420,700 shares $17,230.68 -58.9%N/A0.3 $0.83 2/29/202450,300 shares $39,686.70 +61.7%N/A0.2 $0.79 2/15/202431,100 shares $21,645.60 -42.9%N/A0.1 $0.70 1/31/202454,500 shares $37,114.50 -44.8%N/A0.2 $0.68 1/15/202498,700 shares $70,175.70 -30.5%N/A0.4 $0.71 Get the Latest News and Ratings for ONTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Onconova Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023142,100 shares $105,949.76 -51.5%N/A0.5 $0.75 12/15/2023293,000 shares $224,701.70 +694.0%N/A1.1 $0.77 11/30/202336,900 shares $25,424.10 -56.8%N/A0.3 $0.69 11/15/202385,500 shares $53,950.50 +21.1%N/A1.2 $0.63 10/31/202370,600 shares $44,520.36 +9.0%N/A1 $0.63 10/15/202364,800 shares $43,422.48 +27.8%N/A0.8 $0.67 9/30/202350,700 shares $36,067.98 -36.2%N/A1 $0.71 9/15/202379,400 shares $64,306.06 +23.9%N/A1.4 $0.81 8/31/202364,100 shares $50,382.60 -28.1%N/A1 $0.79 8/15/202389,100 shares $77,802.12 -15.5%N/A1.3 $0.87 7/31/2023105,400 shares $109,616.00 -38.0%N/A1.2 $1.04 7/15/2023170,000 shares $188,700.00 -22.3%N/A0.3 $1.11 6/30/2023218,700 shares $258,066.00 -17.9%N/A0.4 $1.18 6/15/2023266,500 shares $322,465.00 -0.3%N/A0.5 $1.21 5/31/2023267,200 shares $312,624.00 -8.3%N/A0.5 $1.17 5/15/2023291,400 shares $343,852.00 -24.8%N/A0.5 $1.18 4/30/2023387,400 shares $445,510.00 +982.1%N/A0.7 $1.15 4/15/202335,800 shares $24,165.00 +49.2%N/A0.1 $0.68 3/31/202324,000 shares $17,536.80 -38.5%N/A0.1 $0.73 3/15/202339,000 shares $28,587.00 +20.4%N/A0.2 $0.73 2/28/202332,400 shares $26,276.40 +68.8%N/A0.2 $0.81 2/15/202319,200 shares $17,362.56 +64.1%N/A0.1 $0.90 1/31/202311,700 shares $14,625.00 +54.0%N/A0.1 $1.25 1/15/20237,600 shares $6,687.25 -12.6%N/A0.1 $0.88 12/30/20228,700 shares $5,617.59 +19.2%N/A0.1 $0.65 12/15/20227,300 shares $5,158.55 -42.1%N/A0.1 $0.71 11/30/202212,600 shares $10,521.00 -23.2%N/A0.2 $0.84 11/15/202216,400 shares $13,776.00 -58.8%N/A0.2 $0.84 10/31/202239,800 shares $28,656.00 +186.3%N/A0.6 $0.72 10/15/202213,900 shares $9,727.22 -9.7%N/A0.1 $0.70 9/30/202215,400 shares $13,567.40 -16.8%N/A0.2 $0.88 9/15/202218,500 shares $21,645.00 -33.5%N/A0.2 $1.17 8/31/202227,800 shares $33,221.00 +86.6%N/A0.3 $1.20 8/15/202214,900 shares $18,923.00 -12.9%N/A0.1 $1.27The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 7/31/202217,100 shares $20,596.95 -46.2%N/A0.1 $1.20 7/15/202231,800 shares $40,386.00 -14.8%N/A0.3 $1.27 6/30/202237,300 shares $49,236.00 +103.8%N/A0.4 $1.32 6/15/202218,300 shares $21,777.00 -72.2%N/A0.2 $1.19 5/31/202265,800 shares $77,644.00 -25.8%N/A0.6 $1.18 5/15/202288,700 shares $95,796.00 +26.5%N/A0.7 $1.08 4/30/202270,100 shares $97,439.00 +33.5%N/A0.5 $1.39 4/15/202252,500 shares $84,525.00 -23.3%N/A0.3 $1.61 3/31/202268,400 shares $125,856.00 +15.9%N/A0.4 $1.84 3/15/202259,000 shares $88,500.00 -65.7%N/A0.3 $1.50 2/28/2022171,900 shares $278,478.00 -18.1%N/A0.7 $1.62 2/15/2022209,900 shares $358,929.00 +42.7%N/A0.8 $1.71 1/31/2022147,100 shares $286,845.00 -31.3%N/A0.5 $1.95 1/15/2022214,200 shares $475,524.00 +112.1%N/A0.6 $2.22 12/31/2021101,000 shares $257,550.00 -17.0%N/A0.3 $2.55 12/15/2021121,700 shares $340,760.00 -38.4%N/A0.2 $2.80 11/30/2021197,400 shares $592,200.00 -43.4%N/A0.1 $3.00 11/15/2021348,500 shares $1.23 million -20.5%N/A0.2 $3.53 10/29/2021438,200 shares $1.52 million -52.6%N/A0.2 $3.46 10/15/2021923,500 shares $3.39 million -12.9%N/A0.5 $3.67 9/30/20211,060,000 shares $4.06 million +90.1%N/A0.6 $3.83 9/15/2021557,600 shares $2.70 million -16.2%3.8%0.3 $4.84 8/31/2021665,200 shares $3.55 million -7.8%4.5%1.8 $5.33 8/13/2021721,300 shares $3.58 million +12.3%4.9%1.1 $4.96 7/30/2021642,600 shares $3.19 million -18.7%4.3%0.5 $4.97 7/15/2021790,100 shares $4.23 million +9.8%5.3%0.6 $5.35 6/30/2021719,800 shares $4.99 million -25.7%4.9%0.6 $6.93 6/15/2021969,100 shares $6.91 million +34.6%6.6%0.7 $7.13 5/28/2021719,900 shares $4.82 million -82.4%4.9%0.5 $6.69 5/14/20214,080,000 shares $30.75 million -37.1%N/A2.6 $7.54 4/30/20216,490,000 shares $70.77 million +7.8%N/A0.2 $10.91 4/15/20216,020,000 shares $4.17 million -40.9%N/A0.1 $0.69 3/31/202110,180,000 shares $9.98 million -12.4%N/A0.2 $0.98 3/15/202111,620,000 shares $12.90 million -36.3%N/A0.2 $1.11 2/26/202118,240,000 shares $24.81 million +11.6%N/A0.3 $1.36 2/12/202116,350,000 shares $18.97 million +29.0%N/A0.3 $1.16 1/29/202112,670,000 shares $8.81 million -12.3%N/A0.4 $0.70 1/15/202114,450,000 shares $10.34 million +1.7%N/A0.6 $0.72 12/31/202014,210,000 shares $7.24 million +45.3%N/A0.6 $0.51 12/15/20209,780,000 shares $3.22 million -9.9%N/A0.7 $0.33 11/30/202010,860,000 shares $2.82 million -5.0%N/A0.7 $0.26 11/15/202011,430,000 shares $3.02 million -2.6%N/A0.8 $0.26 10/30/202011,730,000 shares $3.11 million -3.3%N/A0.7 $0.27 10/15/202012,130,000 shares $3.83 million -8.3%N/A0.7 $0.32 9/30/202013,220,000 shares $3.70 million -12.1%N/A0.6 $0.28 9/15/202015,040,000 shares $3.48 million +42.4%N/A0.7 $0.23 8/31/202010,560,000 shares $2.54 million -7.0%N/A0.5 $0.24 8/14/202011,350,000 shares $10.73 million -1.2%N/A0.6 $0.95 7/31/202011,490,000 shares $13.21 million +46.4%N/A0.7 $1.15 7/15/20207,850,000 shares $4.53 million -8.3%N/A0.5 $0.58The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 6/30/20208,560,000 shares $4.85 million +34.4%N/A0.8 $0.57 6/15/20206,370,000 shares $3.83 million -18.3%N/A0.6 $0.60 5/29/20207,800,000 shares $3.26 million +3.7%N/A1 $0.42 5/15/20207,520,000 shares $2.71 million +3.4%N/A0.9 $0.36 4/30/20207,270,000 shares $2.29 million +3.3%N/A0.6 $0.31 4/15/20207,040,000 shares $2.20 million -10.2%N/A0.5 $0.31 3/31/20207,840,000 shares $2.35 million -6.8%N/A0.5 $0.30 3/13/20208,415,400 shares $2.61 million +31.9%N/A0.8 $0.31 2/28/20206,380,000 shares $2.04 million -1.2%N/A0.3 $0.32 2/14/20206,460,000 shares $2.58 million +41.4%N/A0.3 $0.40 1/31/20204,570,000 shares $2.19 million -18.8%N/A0.2 $0.48 1/15/20205,630,000 shares $2.87 million +29.4%N/A0.3 $0.51 12/31/20194,350,000 shares $1.65 million +15.1%N/A0.3 $0.38 9/15/2019320,300 shares $342,721.00 -12.2%5.6%2.1 $1.07 8/15/2019396,300 shares $935,268.00 -8.2%7.3%12 $2.36 ONTX Short Interest - Frequently Asked Questions What is Onconova Therapeutics' current short interest? Short interest is the volume of Onconova Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 26,200 shares of ONTX short. Learn More on Onconova Therapeutics' current short interest. What is a good short interest ratio for Onconova Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONTX shares currently have a short interest ratio of 1.0. Learn More on Onconova Therapeutics's short interest ratio. Is Onconova Therapeutics' short interest increasing or decreasing? Onconova Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 26,200 shares, an increase of 26.6% from the previous total of 20,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Onconova Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Onconova Therapeutics: Moleculin Biotech, Inc. (1.53%), Tiziana Life Sciences Ltd (0.16%), vTv Therapeutics Inc. (1.84%), Assembly Biosciences, Inc. (0.58%), Oncolytics Biotech Inc. (1.14%), Annovis Bio, Inc. (13.25%), SELLAS Life Sciences Group, Inc. (12.55%), Spero Therapeutics, Inc. (0.92%), Hookipa Pharma Inc (1.11%), Aclaris Therapeutics, Inc. (6.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Onconova Therapeutics stock? Short selling ONTX is an investing strategy that aims to generate trading profit from Onconova Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Onconova Therapeutics? A short squeeze for Onconova Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ONTX, which in turn drives the price of the stock up even further. How often is Onconova Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONTX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Moleculin Biotech Short Interest Tiziana Life Sciences Short Interest vTv Therapeutics Short Interest Assembly Biosciences Short Interest Oncolytics Biotech Short Interest Annovis Bio Short Interest SELLAS Life Sciences Group Short Interest Spero Therapeutics Short Interest Hookipa Pharma Short Interest Aclaris Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ONTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconova Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.